Basal epithelial stem cells are efficient targets for prostate cancer initiation.

Area of Science:

• Oncology
• Stem Cell Biology
• Urology

Background:

• Current theories propose prostate cancer arises from luminal cells, evidenced by basal cell depletion and luminal cell proliferation.
• Histological definitions of prostate cancer focus on basal cell loss and malignant luminal cell expansion.

Purpose of the Study:

• To investigate the potential of basal/stem cells versus luminal cells as the cell of origin for prostate cancer.
• To evaluate the role of specific signaling pathways (FGF, ERG1, PI3K, Androgen Receptor) in prostate cancer initiation.

Main Methods:

• Genetic alterations were introduced into prospectively isolated murine basal/stem and luminal cells.
• An in vivo prostate regeneration assay was utilized to observe cancer initiation.
• Key signaling pathways including FGF, ERG1, PI3K, and Androgen Receptor signaling were manipulated and evaluated.

Main Results:

• Basal/stem cells demonstrated a significant capacity for cancer initiation when genetically altered.
• Luminal cells failed to initiate cancer under the tested conditions.
• Genetically altered basal/stem cells produced tumors exhibiting luminal-like characteristics, mirroring human prostate cancer.

Conclusions:

• Basal epithelial stem cells are a viable cell of origin for prostate cancer initiation.
• This study challenges prevailing theories by identifying primitive stem cells as a key target for prostate cancer development.
• The findings highlight the inherent tumorigenic potential of stem cells in the prostate.